Correlation Between Nuvectis Pharma and Syndax Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Nuvectis Pharma and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Syndax Pharmaceuticals.

Diversification Opportunities for Nuvectis Pharma and Syndax Pharmaceuticals

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Nuvectis and Syndax is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Syndax Pharmaceuticals go up and down completely randomly.

Pair Corralation between Nuvectis Pharma and Syndax Pharmaceuticals

Given the investment horizon of 90 days Nuvectis Pharma is expected to generate 1.91 times more return on investment than Syndax Pharmaceuticals. However, Nuvectis Pharma is 1.91 times more volatile than Syndax Pharmaceuticals. It trades about 0.17 of its potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about 0.04 per unit of risk. If you would invest  469.00  in Nuvectis Pharma on October 20, 2024 and sell it today you would earn a total of  80.00  from holding Nuvectis Pharma or generate 17.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Nuvectis Pharma  vs.  Syndax Pharmaceuticals

 Performance 
       Timeline  
Nuvectis Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nuvectis Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Nuvectis Pharma is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Syndax Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Syndax Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Nuvectis Pharma and Syndax Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nuvectis Pharma and Syndax Pharmaceuticals

The main advantage of trading using opposite Nuvectis Pharma and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.
The idea behind Nuvectis Pharma and Syndax Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Share Portfolio
Track or share privately all of your investments from the convenience of any device